Condition: Mild to Moderate Corneal Endothelial Decompensation · Bullous Keratopathy · Fuchs' Endothelial Dystrophy · Sponsor: Singapore Eye Research Institute
Assessment of safety and efficacy of tissue-engineered corneal endothelial graft material generated using cultured human corneal endothelial cells for tissue-engineered endothelial keratoplasty (TE-EK).
This description comes directly from the study's public registry record.
Lee Yan Lim · +65 6576 7322 · lim.lee.yan@seri.com.sg
Always discuss trial participation with your own doctor first.
| Singapore Eye Research Institute | Singapore, Singapore | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04319848